Literature DB >> 22072393

Gene-gene interactions in breast cancer susceptibility.

Clare Turnbull1, Sheila Seal, Anthony Renwick, Margaret Warren-Perry, Deborah Hughes, Anna Elliott, David Pernet, Susan Peock, Julian W Adlard, Julian Barwell, Jonathan Berg, Angela F Brady, Carole Brewer, Glen Brice, Cyril Chapman, Jackie Cook, Rosemarie Davidson, Alan Donaldson, Fiona Douglas, Lynn Greenhalgh, Alex Henderson, Louise Izatt, Ajith Kumar, Fiona Lalloo, Zosia Miedzybrodzka, Patrick J Morrison, Joan Paterson, Mary Porteous, Mark T Rogers, Susan Shanley, Lisa Walker, Munaza Ahmed, Diana Eccles, D Gareth Evans, Peter Donnelly, Douglas F Easton, Michael R Stratton, Nazneen Rahman.   

Abstract

There have been few definitive examples of gene-gene interactions in humans. Through mutational analyses in 7325 individuals, we report four interactions (defined as departures from a multiplicative model) between mutations in the breast cancer susceptibility genes ATM and CHEK2 with BRCA1 and BRCA2 (case-only interaction between ATM and BRCA1/BRCA2 combined, P = 5.9 × 10(-4); ATM and BRCA1, P= 0.01; ATM and BRCA2, P= 0.02; CHEK2 and BRCA1/BRCA2 combined, P = 2.1 × 10(-4); CHEK2 and BRCA1, P= 0.01; CHEK2 and BRCA2, P= 0.01). The interactions are such that the resultant risk of breast cancer is lower than the multiplicative product of the constituent risks, and plausibly reflect the functional relationships of the encoded proteins in DNA repair. These findings have important implications for models of disease predisposition and clinical translation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072393      PMCID: PMC4125627          DOI: 10.1093/hmg/ddr525

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Authors: 
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

Review 2.  The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

Authors:  Joanne Smith; Lye Mun Tho; Naihan Xu; David A Gillespie
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

3.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.

Authors:  Antonis C Antoniou; Xianshu Wang; Zachary S Fredericksen; Lesley McGuffog; Robert Tarrell; Olga M Sinilnikova; Sue Healey; Jonathan Morrison; Christiana Kartsonaki; Timothy Lesnick; Maya Ghoussaini; Daniel Barrowdale; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Diana Eccles; D Gareth Evans; Ros Eeles; Louise Izatt; Carol Chu; Fiona Douglas; Joan Paterson; Dominique Stoppa-Lyonnet; Claude Houdayer; Sylvie Mazoyer; Sophie Giraud; Christine Lasset; Audrey Remenieras; Olivier Caron; Agnès Hardouin; Pascaline Berthet; Frans B L Hogervorst; Matti A Rookus; Agnes Jager; Ans van den Ouweland; Nicoline Hoogerbrugge; Rob B van der Luijt; Hanne Meijers-Heijboer; Encarna B Gómez García; Peter Devilee; Maaike P G Vreeswijk; Jan Lubinski; Anna Jakubowska; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Cezary Cybulski; Amanda B Spurdle; Helene Holland; David E Goldgar; Esther M John; John L Hopper; Melissa Southey; Saundra S Buys; Mary B Daly; Mary-Beth Terry; Rita K Schmutzler; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Sabine Preisler-Adams; Norbert Arnold; Dieter Niederacher; Christian Sutter; Susan M Domchek; Katherine L Nathanson; Timothy Rebbeck; Joanne L Blum; Marion Piedmonte; Gustavo C Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Stephanie V Blank; Eitan Friedman; Bella Kaufman; Yael Laitman; Roni Milgrom; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Tomas Kirchhoff; Joseph Vijai; Mia M Gaudet; David Altshuler; Candace Guiducci; Niklas Loman; Katja Harbst; Johanna Rantala; Hans Ehrencrona; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Alessandra Viel; Paolo Radice; Trinidad Caldes; Miguel de la Hoya; Christian F Singer; Anneliese Fink-Retter; Mark H Greene; Phuong L Mai; Jennifer T Loud; Lucia Guidugli; Noralane M Lindor; Thomas V O Hansen; Finn C Nielsen; Ignacio Blanco; Conxi Lazaro; Judy Garber; Susan J Ramus; Simon A Gayther; Catherine Phelan; Stephen Narod; Csilla I Szabo; Javier Benitez; Ana Osorio; Heli Nevanlinna; Tuomas Heikkinen; Maria A Caligo; Mary S Beattie; Ute Hamann; Andrew K Godwin; Marco Montagna; Cinzia Casella; Susan L Neuhausen; Beth Y Karlan; Nadine Tung; Amanda E Toland; Jeffrey Weitzel; Olofunmilayo Olopade; Jacques Simard; Penny Soucy; Wendy S Rubinstein; Adalgeir Arason; Gad Rennert; Nicholas G Martin; Grant W Montgomery; Jenny Chang-Claude; Dieter Flesch-Janys; Hiltrud Brauch; Gianluca Severi; Laura Baglietto; Angela Cox; Simon S Cross; Penelope Miron; Sue M Gerty; William Tapper; Drakoulis Yannoukakos; George Fountzilas; Peter A Fasching; Matthias W Beckmann; Isabel Dos Santos Silva; Julian Peto; Diether Lambrechts; Robert Paridaens; Thomas Rüdiger; Asta Försti; Robert Winqvist; Katri Pylkäs; Robert B Diasio; Adam M Lee; Jeanette Eckel-Passow; Celine Vachon; Fiona Blows; Kristy Driver; Alison Dunning; Paul P D Pharoah; Kenneth Offit; V Shane Pankratz; Hakon Hakonarson; Georgia Chenevix-Trench; Douglas F Easton; Fergus J Couch
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 38.330

4.  Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Authors:  Hanne Meijers-Heijboer; Ans van den Ouweland; Jan Klijn; Marijke Wasielewski; Anja de Snoo; Rogier Oldenburg; Antoinette Hollestelle; Mark Houben; Ellen Crepin; Monique van Veghel-Plandsoen; Fons Elstrodt; Cornelia van Duijn; Carina Bartels; Carel Meijers; Mieke Schutte; Lesley McGuffog; Deborah Thompson; Douglas Easton; Nayanta Sodha; Sheila Seal; Rita Barfoot; Jon Mangion; Jenny Chang-Claude; Diana Eccles; Rosalind Eeles; D Gareth Evans; Richard Houlston; Victoria Murday; Steven Narod; Tamara Peretz; Julian Peto; Catherine Phelan; Hong Xiang Zhang; Csilla Szabo; Peter Devilee; David Goldgar; P Andrew Futreal; Katherine L Nathanson; Barbara Weber; Nazneen Rahman; Michael R Stratton
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

5.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Antonis C Antoniou; Amanda B Spurdle; Olga M Sinilnikova; Sue Healey; Karen A Pooley; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Norbert Arnold; Wera Hofmann; Christian Sutter; Dieter Niederacher; Helmut Deissler; Trinidad Caldes; Kati Kämpjärvi; Heli Nevanlinna; Jacques Simard; Jonathan Beesley; Xiaoqing Chen; Susan L Neuhausen; Timothy R Rebbeck; Theresa Wagner; Henry T Lynch; Claudine Isaacs; Jeffrey Weitzel; Patricia A Ganz; Mary B Daly; Gail Tomlinson; Olufunmilayo I Olopade; Joanne L Blum; Fergus J Couch; Paolo Peterlongo; Siranoush Manoukian; Monica Barile; Paolo Radice; Csilla I Szabo; Lutecia H Mateus Pereira; Mark H Greene; Gad Rennert; Flavio Lejbkowicz; Ofra Barnett-Griness; Irene L Andrulis; Hilmi Ozcelik; Anne-Marie Gerdes; Maria A Caligo; Yael Laitman; Bella Kaufman; Roni Milgrom; Eitan Friedman; Susan M Domchek; Katherine L Nathanson; Ana Osorio; Gemma Llort; Roger L Milne; Javier Benítez; Ute Hamann; Frans B L Hogervorst; Peggy Manders; Marjolijn J L Ligtenberg; Ans M W van den Ouweland; Susan Peock; Margaret Cook; Radka Platte; D Gareth Evans; Rosalind Eeles; Gabriella Pichert; Carol Chu; Diana Eccles; Rosemarie Davidson; Fiona Douglas; Andrew K Godwin; Laure Barjhoux; Sylvie Mazoyer; Hagay Sobol; Violaine Bourdon; François Eisinger; Agnès Chompret; Corinne Capoulade; Brigitte Bressac-de Paillerets; Gilbert M Lenoir; Marion Gauthier-Villars; Claude Houdayer; Dominique Stoppa-Lyonnet; Georgia Chenevix-Trench; Douglas F Easton
Journal:  Am J Hum Genet       Date:  2008-03-20       Impact factor: 11.025

6.  Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Authors:  Antonis C Antoniou; Olga M Sinilnikova; Lesley McGuffog; Sue Healey; Heli Nevanlinna; Tuomas Heikkinen; Jacques Simard; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Susan L Neuhausen; Yuan C Ding; Fergus J Couch; Xianshu Wang; Zachary Fredericksen; Paolo Peterlongo; Bernard Peissel; Bernardo Bonanni; Alessandra Viel; Loris Bernard; Paolo Radice; Csilla I Szabo; Lenka Foretova; Michal Zikan; Kathleen Claes; Mark H Greene; Phuong L Mai; Gad Rennert; Flavio Lejbkowicz; Irene L Andrulis; Hilmi Ozcelik; Gord Glendon; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Maria A Caligo; Yael Laitman; Tair Kontorovich; Shimrit Cohen; Bella Kaufman; Efrat Dagan; Ruth Gershoni Baruch; Eitan Friedman; Katja Harbst; Gisela Barbany-Bustinza; Johanna Rantala; Hans Ehrencrona; Per Karlsson; Susan M Domchek; Katherine L Nathanson; Ana Osorio; Ignacio Blanco; Adriana Lasa; Javier Benítez; Ute Hamann; Frans B L Hogervorst; Matti A Rookus; J Margriet Collee; Peter Devilee; Marjolijn J Ligtenberg; Rob B van der Luijt; Cora M Aalfs; Quinten Waisfisz; Juul Wijnen; Cornelis E P van Roozendaal; Susan Peock; Margaret Cook; Debra Frost; Clare Oliver; Radka Platte; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Rosemarie Davidson; Carol Chu; Diana Eccles; Trevor Cole; Shirley Hodgson; Andrew K Godwin; Dominique Stoppa-Lyonnet; Bruno Buecher; Mélanie Léoné; Brigitte Bressac-de Paillerets; Audrey Remenieras; Olivier Caron; Gilbert M Lenoir; Nicolas Sevenet; Michel Longy; Sandra Fert Ferrer; Fabienne Prieur; David Goldgar; Alexander Miron; Esther M John; Saundra S Buys; Mary B Daly; John L Hopper; Mary Beth Terry; Yosuf Yassin; Christian Singer; Daphne Gschwantler-Kaulich; Christine Staudigl; Thomas v O Hansen; Rosa Bjork Barkardottir; Tomas Kirchhoff; Prodipto Pal; Kristi Kosarin; Kenneth Offit; Marion Piedmonte; Gustavo C Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Peter E Schwartz; Stephanie V Blank; Amanda E Toland; Marco Montagna; Cinzia Casella; Evgeny N Imyanitov; Anna Allavena; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Dieter Niederacher; Helmut Deissler; Britta Fiebig; Christian Suttner; Ines Schönbuchner; Dorothea Gadzicki; Trinidad Caldes; Miguel de la Hoya; Karen A Pooley; Douglas F Easton; Georgia Chenevix-Trench
Journal:  Hum Mol Genet       Date:  2009-08-05       Impact factor: 6.150

7.  Genome-wide association study identifies five new breast cancer susceptibility loci.

Authors:  Clare Turnbull; Shahana Ahmed; Jonathan Morrison; David Pernet; Anthony Renwick; Mel Maranian; Sheila Seal; Maya Ghoussaini; Sarah Hines; Catherine S Healey; Deborah Hughes; Margaret Warren-Perry; William Tapper; Diana Eccles; D Gareth Evans; Maartje Hooning; Mieke Schutte; Ans van den Ouweland; Richard Houlston; Gillian Ross; Cordelia Langford; Paul D P Pharoah; Michael R Stratton; Alison M Dunning; Nazneen Rahman; Douglas F Easton
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

8.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

Authors:  Amy Strange; Francesca Capon; Chris C A Spencer; Jo Knight; Michael E Weale; Michael H Allen; Anne Barton; Gavin Band; Céline Bellenguez; Judith G M Bergboer; Jenefer M Blackwell; Elvira Bramon; Suzannah J Bumpstead; Juan P Casas; Michael J Cork; Aiden Corvin; Panos Deloukas; Alexander Dilthey; Audrey Duncanson; Sarah Edkins; Xavier Estivill; Oliver Fitzgerald; Colin Freeman; Emiliano Giardina; Emma Gray; Angelika Hofer; Ulrike Hüffmeier; Sarah E Hunt; Alan D Irvine; Janusz Jankowski; Brian Kirby; Cordelia Langford; Jesús Lascorz; Joyce Leman; Stephen Leslie; Lotus Mallbris; Hugh S Markus; Christopher G Mathew; W H Irwin McLean; Ross McManus; Rotraut Mössner; Loukas Moutsianas; Asa T Naluai; Frank O Nestle; Giuseppe Novelli; Alexandros Onoufriadis; Colin N A Palmer; Carlo Perricone; Matti Pirinen; Robert Plomin; Simon C Potter; Ramon M Pujol; Anna Rautanen; Eva Riveira-Munoz; Anthony W Ryan; Wolfgang Salmhofer; Lena Samuelsson; Stephen J Sawcer; Joost Schalkwijk; Catherine H Smith; Mona Ståhle; Zhan Su; Rachid Tazi-Ahnini; Heiko Traupe; Ananth C Viswanathan; Richard B Warren; Wolfgang Weger; Katarina Wolk; Nicholas Wood; Jane Worthington; Helen S Young; Patrick L J M Zeeuwen; Adrian Hayday; A David Burden; Christopher E M Griffiths; Juha Kere; André Reis; Gilean McVean; David M Evans; Matthew A Brown; Jonathan N Barker; Leena Peltonen; Peter Donnelly; Richard C Trembath
Journal:  Nat Genet       Date:  2010-10-17       Impact factor: 38.330

9.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.

Authors:  Sheila Seal; Deborah Thompson; Anthony Renwick; Anna Elliott; Patrick Kelly; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Munaza Ahmed; Katarina Spanova; Bernard North; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-10-08       Impact factor: 38.330

10.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  15 in total

1.  CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.

Authors:  Petra E A Huijts; Antoinette Hollestelle; Brunilda Balliu; Jeanine J Houwing-Duistermaat; Caro M Meijers; Jannet C Blom; Bahar Ozturk; Elly M M Krol-Warmerdam; Juul Wijnen; Els M J J Berns; John W M Martens; Caroline Seynaeve; Lambertus A Kiemeney; Henricus F van der Heijden; Rob A E M Tollenaar; Peter Devilee; Christi J van Asperen
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

2.  Rare mutations in XRCC2 increase the risk of breast cancer.

Authors:  D J Park; F Lesueur; T Nguyen-Dumont; M Pertesi; F Odefrey; F Hammet; S L Neuhausen; E M John; I L Andrulis; M B Terry; M Daly; S Buys; F Le Calvez-Kelm; A Lonie; B J Pope; H Tsimiklis; C Voegele; F M Hilbers; N Hoogerbrugge; A Barroso; A Osorio; G G Giles; P Devilee; J Benitez; J L Hopper; S V Tavtigian; D E Goldgar; M C Southey
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

Review 3.  Management of familial cancer: sequencing, surveillance and society.

Authors:  Nardin Samuel; Anita Villani; Conrad V Fernandez; David Malkin
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

4.  Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer.

Authors:  Molly Scannell Bryan; Maria Argos; Irene L Andrulis; John L Hopper; Jenny Chang-Claude; Kathleen E Malone; Esther M John; Marilie D Gammon; Mary B Daly; Mary Beth Terry; Saundra S Buys; Dezheng Huo; Olofunmilayo I Olopade; Jeanine M Genkinger; Alice S Whittemore; Farzana Jasmine; Muhammad G Kibriya; Lin S Chen; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-13       Impact factor: 4.254

5.  Variation in cancer risk among families with genetic susceptibility.

Authors:  Theodore Huang; Danielle Braun; Henry T Lynch; Giovanni Parmigiani
Journal:  Genet Epidemiol       Date:  2020-10-08       Impact factor: 2.135

6.  Gene network inference by fusing data from diverse distributions.

Authors:  Marinka Žitnik; Blaž Zupan
Journal:  Bioinformatics       Date:  2015-06-15       Impact factor: 6.937

7.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.

Authors:  Shanbeh Zienolddiny; Aage Haugen; Jenny-Anne Sigstad Lie; Helge Kjuus; Kristine Haugen Anmarkrud; Kristina Kjærheim
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

Review 8.  Realizing the promise of cancer predisposition genes.

Authors:  Nazneen Rahman
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

9.  Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.

Authors:  Maria Peña-Chilet; Maite Blanquer-Maceiras; Maider Ibarrola-Villava; Conrado Martinez-Cadenas; Manuel Martin-Gonzalez; Cristina Gomez-Fernandez; Matias Mayor; Juan Antonio Aviles; Ana Lluch; Gloria Ribas
Journal:  BMC Cancer       Date:  2013-03-27       Impact factor: 4.430

10.  Properties of local interactions and their potential value in complementing genome-wide association studies.

Authors:  Wenhua Wei; Attila Gyenesei; Colin A M Semple; Chris S Haley
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.